While the COVID-19 pandemic is far from over, there have been some small glimmers of hope in recent days – and the market responded accordingly. Against this backdrop, Wall Street pros argue that “those ready to take on some risk have been presented with exciting opportunities” – especially within the biotech space. For three biotech stocks trading under $2 with “serious upside potential” – including one biotech firm whose upside potential is related in part to its potential treatment for COVID-19, CLICK HERE.